| Literature DB >> 33546055 |
Kwan Jae Kim1, Jin Hong Min2,3, Insool Yoo1,2, Seung Whan Kim1,2, Jinwoong Lee1, Seung Ryu1, Yeon Ho You1, Jung Soo Park1,2, Won Joon Jeong1, Yong Chul Cho1, Se Kwang Oh3, Yong Nam In3, Hong Joon Ahn1, Chang Shin Kang1, Hyunwoo Kyung4, Byung Kook Lee5,6, Dong Hun Lee6, Dong Hoon Lee7.
Abstract
ABSTRACT: This retrospective cohort study aimed to compare the effectiveness of conventional treatment and ultra-early application of negative pressure wound therapy (NPWT) in patients with snakebites.Patients who visited the emergency department within 24 hours after a snakebite were assigned to the non- NPWT or NPWT group. Swelling resolution time and rates of necrosis, infection, and operations were compared between the 2 groups. The Stony Brook Scar Evaluation Scale was used to measure short- and long-term wound healing results.Among the included 61 patients, the swelling resolution time was significantly shorter in the NPWT group than in non- NPWT group (P = .010). The NPWT group showed lower necrosis (4.3% versus 36.8%; P = .003) and infection (13.2% and 4.3%; P = .258) rates than the non- NPWT group. The median Stony Brook Scar Evaluation Scale scores were higher in the NPWT group than in the non- NPWT group (P< .001).These findings suggest that ultra-early application of NPWT reduces edema, promotes wound healing, and prevents necrosis in patients with snakebites.Entities:
Mesh:
Year: 2021 PMID: 33546055 PMCID: PMC7837876 DOI: 10.1097/MD.0000000000024290
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.889
The Stony Brook Scar Evaluation Scale.
| Scar category | Points |
| Width | |
| >2mm | 0 |
| ≤2 mm | 1 |
| Height | |
| Elevated/depressed in relation to surrounding skin | 0 |
| Flat | 1 |
| Color | |
| Darker than surrounding skin | 0 |
| Same color or lighter than surrounding skin | 1 |
| Hatch marks/Suture marks | |
| Present | 0 |
| Absent | 1 |
| Overall appearance | |
| Poor | 0 |
| Good | 1 |
Figure 1Flow diagram of patient enrollment. A total of 61 patients were enrolled; 38 patients underwent conventional treatment, and 23 received ultra-early NPWT. NPWT, negative pressure wound therapy.
General characteristics, blood test results, and initial wound status of enrolled patients.
| Cohort (n = 61) | Non-NPWT (n = 38) | NPWT (n = 23) | ||
| Male, n (%) | 36 (59.0) | 21 (55.2) | 15 (65.2) | .592 |
| Age, yr median (IQR) | 61 (56–71) | 60 (53.7–69.5) | 66 (58.0–73.0) | .198 |
| Past medical history | ||||
| Hypertension, n (%) | 16 (26) | 9 (23.6) | 7 (30.4) | .765 |
| Diabetes, n (%) | 3 (5) | 0 (0) | 3 (13.0) | .049 |
| Chronic renal disease, n (%) | 1 (2) | 1 (2.6) | 0 (0) | 1.00 |
| Initial laboratory results | ||||
| WBC, x1000/ul, mean (SD) | 8.218 (2.684) | 8.059 (2.821) | 8.480 (2.480) | .413 |
| Hb, g/dl, mean (SD) | 13.80 (1.51) | 13.40 (1.41) | 14.30 (1.54) | .022 |
| NLR, ratio, median (IQR) | 2.75 (1.55–4.37) | 2.31 (1.28–3.84) | 3.94 (1.74–4.91) | .113 |
| CRP, mg/dL, median (IQR) | 0.5 (0.5–0.6) | 0.5 (0.5–0.5) | 0.5 (0.5–0.8) | < .05 |
| BUN, mg/dL, median (IQR) | 16 (13–20) | 17 (13.2–21) | 15 (13–18) | .122 |
| Cr, mg/dL, median (IQR) | 0.76 (0.67–0.93) | 0.76 (0.58–0.93) | 0.76 (0.70–0.94) | .414 |
| INR, ratio, median (IQR) | 0.98 (0.92–1.04) | 1.00 (0.94–1.04) | 0.98 (0.80–1.06) | .290 |
| aPTT, sec, median (IQR) | 28.7 (25.9–31.0) | 29.2 (25.9–31.7) | 28.2 (25.4–30.2) | .188 |
| Antivenin injection time after injury, hr, median (IQR) | 8.0 (4.0–17.0) | 7.5 (4.0–14.6) | 14 (4.0–20.0) | .179 |
| Admission time after injury, hr, median (IQR) | 10 (5–21.5) | 9.0 (5.0–17.3) | 17 (6.0–22.0) | .091 |
| Initial wound status | ||||
| Location | ||||
| Finger, n (%) | 40 (65.6) | 27 (62.5) | 13 (37.5) | .251 |
| Palm, n (%) | 2 (3.3) | 1 (50) | 1 (50) | .718 |
| Foot, n (%) | 14 (23) | 8 (57.1) | 6 (42.9) | .653 |
| Other areas, n (%) | 5 (8.2) | 2 (40) | 3 (60) | .287 |
| Skin color change, n, (%) | 18 (29.5) | 9 (50) | 9 (50) | .160 |
Treatment results in the 2 study groups.
| Cohort (n = 61) | Non-NPWT (n = 38) | NPWT (n = 23) | Relative risk (95% CI) | ||
| Swelling full resolution time, day, median (IQR) | 4.0 (3.0–5.0) | 4.0 (3.0–5.0) | 3.0 (3.0–4.0) | .010 | |
| Necrosis, n (%) | 15 (24.6) | 14 (93.3) | 1 (6.7) | 0.660 (0.510–0.885) | .003 |
| Finger, n (%) | 13 (21.3) | 12 (92.3) | 1 (7.7) | 0.602 (0.415–0.873) | .013 |
| Palm, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 | |
| Foot, n (%) | 2 (3.3) | 2 (100) | 0 (0) | 0.750 (0.503–1.119) | .202 |
| Other areas, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 | |
| Infection, n (%) | 6 (9.8) | 5 (83.3) | 1 (16.7) | 0.908 (0.780–1.056) | .258 |
| Initial skin color change | .160 | ||||
| Yes, n (%) | 18 (29.5) | 9 (50) | 9 (50) | ||
| Necrosis, n (%) | 5 (27.8) | 1 (5.6) | 0.500 (0.232–1.076) | .046 | |
| No, n (%) | 43 (70.5) | 29 (67.4) | 14 (32.6) | ||
| Necrosis, n (%) | 9 (20.9) | 0 (0) | 0.690 (0.540–0.880) | .019 | |
| Operation, n (%) | 3 (4.9) | 3 (100) | 0 (0) | 0.921 (0.893–1.011) | .234 |
Figure 2A) A 66-year-old female patient with a snakebite on her left thumb. (A) Traditional treatment. (B) After 15 days, there was progression of necrosis, including hemorrhagic bullae at the bite site. (C) Wound debridement followed by a skin flap graft. (D) After 2 months, the skin defect persisted. B) A 51-year-old man presented with a snakebite on the right little finger. (A) Skin color changes and hemorrhagic bullae were observed during examination in the emergency department. (B) Wound debridement was undertaken. (C) The patient received ultra-early NPWT. (D) On day 3 of hospitalization, the wound healed without necrosis. C) A 61-year-old man with a snakebite on the right fourth finger. (A) A large hemorrhagic bulla and skin color changes were identified during the visit at the emergency department. (B) Removal of hemorrhagic bullae and wound debridement was undertaken. Ultra-early NPWT was applied, and the patient was discharged 3 days later. (C) Outpatient follow-up after 24 days. (D) At the 6-month follow-up, the patient completely recovered without complications. NPWT, negative pressure wound therapy.
Figure 3A) Comparison of the Stony Brook Scar Evaluation Scale results between Non-NPWT and NPWT groups using the Mann–Whitney U-test. Solid lines indicate the median values with interquartile ranges. B) Comparison of the Stony Brook Scar Evaluation Scale between short and long-term follow-up evaluations for each group using the Wilcoxon signed-rank test. Solid lines indicate median values with interquartile ranges. Circles indicate the short-term follow-up outcomes, whereas squares indicate long-term follow-up outcomes based on the scores of the scar evaluation scale. NPWT, negative pressure wound therapy.